Frelii Inc (FRLI) Dự đoán giá cổ phiếu

Frélii, Inc. provides consumer affordable access to personalized health assessments and nutrition plans based on genetic data, physiology, environmental and lifestyle factors, and lab diagnostics all on one convenient web platform. The company is headquartered in Lehi, Utah. The company went IPO on 2005-01-18. The firm provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies users’ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Company’s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The firm provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. The company provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.